StockData

Quantum Cyber vs Exicure

QUCY and XCUR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How QUCY and XCUR compare

Exicure scores higher on the StockData Score (4 against 3 for Quantum Cyber), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricQUCYXCUR
Size and price
Market cap–$7.0M
Share price$0.630$1.07
Change, 1 year−53.7%−70.7%
Change, 5 years−93.6%−98.6%
Beta (5Y)–−0.97
Employees38
StockData Score
Total score34 (better)
Valuation score00
Growth score1 (better)0
Performance score1 (better)0
Health score14 (better)
Dividend score00
Valuation
P/B–7.2×
Growth
Revenue growth (TTM)−39.9%–
Revenue growth, 5Y average1.7%–
Profitability
Gross margin72.6%–
Operating margin−3005%–
Net margin−3018%–
FCF margin−2045%–
Return on equity−141% (better)−168%
Return on invested capital−324% (better)−4377%
Financial health
Debt / equity–0.00
Interest coverage−43.2×–
Current ratio5.56 (better)0.56
Altman Z-score–−27.36
Piotroski F-score22
Dividends and buybacks
Buyback yield–0.00%
Shareholder yield–0.00%
Ownership
Held by institutions2.4%2.1%
Held by insiders–92.6%
Insider net buying, 12 months$0 (better)−$11.6M
Short interest, % of float–10.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.